InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Kane Matthew R., Chief Executive Officer. Officer active across 1 company, notably Precision Biosciences INC. Aggregated, 2 filings have been logged. History available since 7 May 2021. The latest transaction was disclosed on 13 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kane Matthew R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
21,514 shares@ US$0.0450.0% of flowCommon StockSEC:0001209191-21-032773:0
21,514 shares@ US$0.0450.0% of flowCommon StockSEC:0001209191-21-031670:0
2 of 2 declarations
About Kane Matthew R.
Matthew R. Kane is the President and CEO of Precision BioSciences Inc. In this role, he oversees the company's operations and leads strategic initiatives. Kane is recognized for his expertise in the biopharmaceutical sector and his commitment to innovation.
